Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. - Wikidata - awgldk - TriplyDB

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

http://www.wikidata.org/entity/Q36367135

about

RNA vaccines in cancer treatment Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations.Dendritic cells: In the forefront of immunopathogenesis and vaccine development - A review Gene therapy for carcinoma of the breast: Genetic immunotherapy Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma.Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas.RNA-Based Vaccines in Cancer Immunotherapy Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies Immunotherapy in gastric cancer Messenger RNA-based vaccines: progress, challenges, applications Trial watch: Dendritic cell-based anticancer therapy Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors Emerging clinical applications of RNA Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (Paclitaxel) for murine fibrosarcoma Theranostic mRNA-loaded microbubbles in the lymphatics of dogs: implications for drug delivery.A novel, rapid strategy to form dendritomas from human dendritic cells and hepatocellular carcinoma cell line HCCLM3 cells using mature dendritic cells derived from human peripheral blood CD14+ monocytes within 48 hours of in vitro culture.Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design.Advances in cancer vaccine development.Photodynamic therapy induces interleukin secretion from dendritic cells.Role of dendritic cells in the induction and maintenance of autoimmune diseases.Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma Whole blood cells loaded with messenger RNA as an anti-tumor vaccine.Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells.Cell-based vaccines for the stimulation of immunity to metastatic cancers.TLR7: A new sensor of viral infection.Dendritic cells efficiently induce protective antiviral immunity.New technologies toward dendritic cell-based cancer immunotherapies.Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy.Historical overview of biologic response modifiers.Dendritic cell-based cancer immunotherapy: potential for treatment of colorectal cancer?Management of malignant melanoma: new developments in immune and gene therapy.RNA-transfected dendritic cells in cancer immunotherapy.Advances in gene therapy for malignant melanoma.RNA as a tumor vaccine: a review of the literature.Dendritic cells for specific cancer immunotherapy.

P2860

Q21296852-B84513A8-A5CC-43BE-84F1-C1BD1E6346C6 Q24533572-130F6FE8-CB85-49CA-B843-67C73AFA5730 Q24792153-287AAEDC-DC29-45EF-A316-3DF7A3A15C61 Q24797848-C67CFEC9-E837-4006-B5EA-9AEE8C0471AD Q24804837-B55AD3CB-B352-411C-8B14-D6AAE4A5B754 Q24806024-EE9C9235-2D65-4026-8848-EB41955D34CF Q24814644-1C7992FA-9E02-4F59-960F-D9B9F2B15720 Q24814838-5213A469-69AE-40B7-8861-1B79D5ECF54C Q26776028-40817B7B-209F-4822-9F4A-853546077F5B Q26861563-6878A24C-C49B-48E5-BF90-1E78C0332734 Q26864603-A6D33F59-BF89-4DAD-BE88-402B29B6D842 Q27010472-6722FA1C-B834-431C-8AC6-CD03925C51F3 Q27012738-8C410DB8-09E5-42EA-9DDA-7C5350D7594D Q27024047-8FA5E19C-F999-405B-B4D6-3A06D3433E31 Q28005535-0F614082-0D51-4583-8EFE-1A50666C82AE Q28183577-500A2DF5-9E3E-4CA7-8AA2-8DA7A56F6511 Q28214164-399A02A6-CD1F-4204-8756-455209217A4E Q28468646-DBB188DA-CC77-4588-A798-0FF17F70508F Q30422136-DCDB24DF-44F2-44D1-843C-AC05FE12BEA5 Q33208820-BC9BDF88-8A40-41EC-818C-D13BFA4C8FBA Q33595455-94A313FD-BE3C-4321-BC53-1FC1631213B2 Q33603404-71BEB069-BC65-4E73-9BD8-E22067C736AA Q33626420-035C9C77-0BF4-4690-9547-DABB1E7CA6F8 Q33713274-AE253504-474C-440C-A51B-8AA3A9790F5B Q33732491-6BD06E13-7731-45C8-B190-8987EF975A8B Q33740816-7796F993-7A99-404B-920B-7D4C466A2745 Q33772145-BB382949-2DC3-4F2C-90F6-4FB515B960C5 Q33776134-4178F150-1940-4C1B-A243-F3CB3E187F4E Q33780838-4D51EB5B-3468-400B-873A-DC9A25F14D7A Q33782672-055C9C42-3B54-4E37-B8E1-1E32B5154C6A Q33817903-09FE4B7D-6668-4D95-878B-B93354FAC375 Q33834337-D98B1D7D-6EE6-4810-94CA-10C60DC449E9 Q33846007-6FC7602A-C6F0-4DDC-AACF-700AB7C7773B Q33931138-797FB89F-3D25-4D65-8DAA-13AF509F3A8D Q33999366-301413AB-FCAD-47A5-BB68-A6EB25E1EAAA Q34067644-3BCF064B-42E2-49F6-B8B2-EF4FE2F2B258 Q34078072-4AF34A4D-A58B-4942-B235-06FA477B3B4E Q34119859-88FC73E9-CC04-48C1-B1CA-4785EC5AEE2D Q34266409-9E1FCBDE-1817-41D2-B9F0-6B0574121A33 Q34280913-F628142A-CFD7-4912-8B85-FBF29BBCA8F3

P2860

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

http://www.wikidata.org/entity/Q36367135

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

1996年學術文章

@zh

1996年學術文章

@zh-hant

name

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

@ast

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

@en

type

label

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

@ast

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

@en

prefLabel

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

@ast

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

@en

P1433

Q36367135-88D4BDFE-94B8-4774-9B9C-D2EAD558C7F1

P1476

Q36367135-FCF760B5-FCF4-40EF-B06C-DA25CC00137B

P2093

Q36367135-18FBB605-C20D-41EE-8CA7-28F406F46BB8

Q36367135-1DC7E0AE-DD0C-4163-9011-95A0D545F5A8

Q36367135-804719E3-3242-45B1-8544-E843BAB33F90

Q36367135-9D5F5199-E40B-4DAA-8095-CC18A1A33FAC

P2860

Q36367135-1D0A1877-1017-4697-AA24-3275E821C064

Q36367135-207C8EB7-1504-4888-BF57-C6A8133DE6DB

Q36367135-22628836-DBEB-401D-A6B8-20E0FE75467F

Q36367135-26084C61-8EB0-4A3E-817F-5CD613494867

Q36367135-35987F43-FEF8-4F47-B460-7D4B0107048F

Q36367135-3D38ECC9-B155-4ACA-8395-708D1E3A3A0C

Q36367135-411510F6-6F7B-48E1-9F04-7C5AA81F27B8

Q36367135-42A1D845-5A6F-4EFA-8EDF-86ADBB4F6805

Q36367135-55D44D60-B47D-47AE-AE8C-1EB8E966D099

Q36367135-67325D41-77B1-44E7-8D41-294F64E0282E

P304

Q36367135-A1F13937-B8C9-4460-8044-4D6B8094F0FF

P31

Q36367135-D3B1105E-76A9-4F0D-BB98-6874AEDC288C

P356

Q36367135-1DF6C5B3-E8B7-4B8B-9791-9D97A97ABDF8

P407

Q36367135-CECF84F5-E6DA-4988-B85F-BB73271DC328

P433

Q36367135-F3B73B21-038C-4162-82BD-58600D86BDF4

P478

Q36367135-23C773FD-D362-42FC-A34C-684F1F9F4752

P577

Q36367135-4010CE4F-F694-489A-A38F-34265FA1D7D9

P5875

Q36367135-184CA502-E6B7-4DE7-A913-DD62F45F09E2

P698

Q36367135-D9C7117C-6CEE-4384-B49D-4B9E6E2EF47B

P932

Q36367135-1FE60CB5-B7C8-4C23-B215-2FF0B03235A5

P356

P1433

Journal of Experimental Medicine

P1476

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

@en

P2093

Boczkowski D

http://www.w3.org/2001/XMLSchema#string

Gilboa E

http://www.w3.org/2001/XMLSchema#string

Nair SK

http://www.w3.org/2001/XMLSchema#string

Snyder D

http://www.w3.org/2001/XMLSchema#string

P2860

Human tumor antigens recognized by T lymphocytes

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

The dendritic cell system and its role in immunogenicity

Site specific enzymatic cleavage of RNA.

Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro

Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.

B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.

P304

465-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.184.2.465

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P577

1996-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279401650

http://www.w3.org/2001/XMLSchema#string

P698

8760800

http://www.w3.org/2001/XMLSchema#string

P932

2192710

http://www.w3.org/2001/XMLSchema#string